BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8090727)

  • 1. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.
    Bett AJ; Haddara W; Prevec L; Graham FL
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8802-6. PubMed ID: 8090727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA sequence of the deletion/insertion in early region 3 of Ad5 dl309.
    Bett AJ; Krougliak V; Graham FL
    Virus Res; 1995 Nov; 39(1):75-82. PubMed ID: 8607286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-efficiency Cre/loxP-based system for construction of adenoviral vectors.
    Ng P; Parks RJ; Cummings DT; Evelegh CM; Sankar U; Graham FL
    Hum Gene Ther; 1999 Nov; 10(16):2667-72. PubMed ID: 10566894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foreign gene expression by human adenovirus type 5-based vectors studied using firefly luciferase and bacterial beta-galactosidase genes as reporters.
    Mittal SK; Bett AJ; Prevec L; Graham FL
    Virology; 1995 Jun; 210(1):226-30. PubMed ID: 7793076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.
    Zhou H; O'Neal W; Morral N; Beaudet AL
    J Virol; 1996 Oct; 70(10):7030-8. PubMed ID: 8794347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for construction of adenovirus vectors.
    Graham FL; Prevec L
    Mol Biotechnol; 1995 Jun; 3(3):207-20. PubMed ID: 7552690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D.
    Ruzsics Z; Wagner M; Osterlehner A; Cook J; Koszinowski U; Burgert HG
    J Virol; 2006 Aug; 80(16):8100-13. PubMed ID: 16873266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of high-capacity adenoviral vectors.
    Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
    Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrid yeast-bacteria cloning system used to capture and modify adenoviral and nonviral genomes.
    Hokanson CA; Dora E; Donahue BA; Rivkin M; Finer M; Mendez MJ
    Hum Gene Ther; 2003 Mar; 14(4):329-39. PubMed ID: 12659674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence analysis of bovine adenovirus type 3 early region 3 and fibre protein genes.
    Mittal SK; Prevec L; Babiuk LA; Graham FL
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3295-300. PubMed ID: 1469367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes.
    Marienfeld U; Haack A; Thalheimer P; Schneider-Rasp S; Brackmann HH; Poller W
    Gene Ther; 1999 Jun; 6(6):1101-13. PubMed ID: 10455413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
    Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
    J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and identification of polycistron adenoviral expression vector PCA13/FasL-IRES-iNOS.
    Qiu JF; Wu ZY; Luo CX; Yu FR; Zhang ZQ
    Chin J Dig Dis; 2004; 5(1):40-3. PubMed ID: 15612671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and Large-Scale Production of High-Capacity Adenoviral Vectors Based on the Human Adenovirus Type 5.
    Ehrke-Schulz E; Zhang W; Schiwon M; Bergmann T; Solanki M; Liu J; Boehme P; Leitner T; Ehrhardt A
    J Vis Exp; 2016 Jan; (107):e52894. PubMed ID: 26863087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.
    Eloit M; Adam M
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A convenient plasmid system for construction of helper-dependent adenoviral vectors and its application for analysis of the breast-cancer-specific mammaglobin promoter.
    Shi CX; Graham FL; Hitt MM
    J Gene Med; 2006 Apr; 8(4):442-51. PubMed ID: 16389604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constructing adenoviral vectors by using the circular form of the adenoviral genome cloned in a cosmid and the Cre-loxP recombination system.
    Tashiro F; Niwa H; Miyazaki J
    Hum Gene Ther; 1999 Jul; 10(11):1845-52. PubMed ID: 10446924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human adenovirus cloning vectors based on infectious bacterial plasmids.
    Ghosh-Choudhury G; Haj-Ahmad Y; Brinkley P; Rudy J; Graham FL
    Gene; 1986; 50(1-3):161-71. PubMed ID: 3472993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.
    Imler JL; Bout A; Dreyer D; Dieterlé A; Schultz H; Valerio D; Mehtali M; Pavirani A
    Hum Gene Ther; 1995 Jun; 6(6):711-21. PubMed ID: 7548271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus vectors for renal-targeted gene delivery.
    Appledorn DM; Seregin S; Amalfitano A
    Contrib Nephrol; 2008; 159():47-62. PubMed ID: 18391584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.